Spago Nanomedical is a Swedish biotechnology company developing nanomaterials for cancer diagnostics and treatment. The company´s two main projects,  SpagoPix and Tumorad, are both based on the same proprietary nanomaterial.SpagoPix is a gadolinium-free contrast agent for magnetic resonance imaging (MRI) with exceptionally high signal strength. By selectively accumulating in tumor tissue via passive tumor targeting, SpagoPix meets a well recognized need for significantly improved soft tissue tumor imaging.Tumorad is a nanoprticle loaded with radionuclides being developed to target soft tissue tumors for radiopharmaceutical treatment. The design of Tumorad  enables it to selectively accumulate in tumor tissue and there deliver a controlled radiation dose.

Vinnova

Spago Nanomedical AB

BioInvent International AB is a clinical-stage biotech company focused on the discovery and development of novel immuno-modulatory antibodies for cancer therapy.

BioInvent International AB

Alligator Bioscience AB is a biotechnology company that develops antibody-based pharmaceuticals for cancer treatment.

Alligator Bioscience AB

Oncopeptides AB is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers.

Oncopeptides AB

Spago Nanomedical is a Swedish nanomedicine company in the clinical development phase, focusing on developing products for diagnostics and treatment of life-threatening and debilitating diseases. The company's operations are based on a patented material for the design of functional nanoparticles that accumulate physiologically in tumors, enabling higher diagnostic and therapeutic precision.

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

Spago Nanomedical AB (publ)

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general	Feb 7, 2024 1:02 PM	87ae9f91
news basic	general
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis	Sep 29, 2024 6:40 AM	1aed976d
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

SE:SPAGONANOMEDICAL

Spago Nanomedical AB (publ)

Last Close

0.26

25/09 14:33

Market Cap

107.94M

Beta: -

Volume Today

40.90K

Avg: -